These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20082859)

  • 1. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
    Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
    Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
    Yu KD; Chen AX; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
    Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
    Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
    De Vivo I; Hankinson SE; Colditz GA; Hunter DJ
    Cancer Res; 2003 Sep; 63(17):5236-8. PubMed ID: 14500352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis.
    Yang DS; Park KH; Woo OH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
    Breast Cancer Res Treat; 2011 Feb; 125(3):849-53. PubMed ID: 20652396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.
    Huggins GS; Wong JY; Hankinson SE; De Vivo I
    Cancer Res; 2006 Feb; 66(3):1384-90. PubMed ID: 16452193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
    Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
    Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
    Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
    Tang C; Chen N; Wu M; Yuan H; Du Y
    Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
    Qiu LX; Yao L; Mao C; Chen B; Zhan P; Xue K; Zhang J; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a TGF-β1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis.
    Woo SU; Park KH; Woo OH; Yang DS; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
    Breast Cancer Res Treat; 2010 Nov; 124(2):481-5. PubMed ID: 20361250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
    Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z
    Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
    Lewis SJ; Harbord RM; Harris R; Smith GD
    J Natl Cancer Inst; 2006 Nov; 98(22):1607-22. PubMed ID: 17105984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.